Respiratory specialists, otolaryngologists, allergists, and research and pharma partners, designed to bridge the gap between visits and promote longitudinal health monitoring.

Products

AIRLIE
Remote Respiratory Monitoring

In development. Continuous visibility of respiratory symptoms and treatment response between clinic visits.

Get in touch See RhinoMAP

WHat it is

Closing the blind spot between appointments

Two Diag-nose.io phones showing a health app with symptom check-in and weekly adherence, vitals, and treatment details.

Respiratory care happens in snapshots.

A clinician sees a patient for a few minutes every few months, then makes decisions across weeks of symptoms, adherence and treatment response they never saw.

AIRLIE closes that gap.

It is a continuous monitoring layer that captures validated symptoms, adherence and outcomes data between visits, and organises it into a longitudinal record clinicians can review and research teams can build on.

What AIRLIE aims to do

Continuous, whole-patient monitoring

Continuous visibility

Designed to capture how symptoms progress or improve between visits, so clinical decisions are informed by the full interval rather than a single point in time.

Treatable-traits capture

Built around the treatable-traits framework. Designed to capture pulmonary, extrapulmonary and behavioural traits through validated instruments, making the full clinical picture visible between visits.

Patient-reported outcomes

Designed to collect validated patient-reported outcome measures and score them against recognised clinical thresholds, turning patient symptoms into structured, trackable clinical data.

Secure data sharing

Built around privacy-first data governance and defined access permissions.

How it Fits

What AIRLIE captures:

Symptom trajectories between visits

Adherence and application patterns

Treatment-response patterns

Pulmonary, extrapulmonary and behavioural traits

WHo it's for

For the team managing the whole patient

Respiratory specialists

Otolaryngologists

Allergists

Research and pharma partners running longitudinal programs

Common questions

What is AIRLIE?

An in-development platform for remote respiratory monitoring and secure data sharing, designed to bridge the gap between clinic visits.

What does AIRLIE aim to do?

AIRLIE aims to give clinicians continuous visibility of symptoms, adherence and treatment response between visits, and to capture treatable traits.

Who is AIRLIE for?

Respiratory specialists, otolaryngologists, allergists, and research / pharma partners — designed to bridge the gap between visits and promote longitudinal health monitoring.

Is my data secure?

AIRLIE is built for secure data sharing under privacy-governed agreements.

Is AIRLIE available now?

AIRLIE is in development; timeline to be confirmed. Get in touch for partnership enquiries.

AIRLIE is an investigational technology. It has not been approved by the FDA or any other regulatory authority for diagnostic or clinical use.